A trial looking at denosumab for early breast cancer (D-CARE)

This trial was done to see if denosumab could stop or delay breast cancer spreading to the bones. It was for women who had early breast cancer, and their doctors thought there was a high risk of it coming back or spreading to their bones.

The trial was open for people to join between 2010 and 2012. The team published some results in 2020 and 2021.